ArticleCell biochemistry and biophysics2026
IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.
Wei Jia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.